Based on real word references from multiple hospitals and based on Anyfusion's competitiveness, we participated in the exhibition booth at the Hospital Intensive Care Medicine Society on March 29th and the Korean Society of Critical Care Medicine on April 24-25.

Just as the FDA classified the existing pump as an inappropriate drug infusion pump due to safety and oil problems, all medical staff in Korea are aware of the serious problems with existing drug infusion pumps. Therefore, it was confirmed that the safety and oil problems were resolved in hospitals that were already using it, and the introduction of a pump with proven technology had a significant exhibition effect.

While the Hospital Critical Care Nursing Association was introduced to nurses who are actual users, the Korean Society of Critical Care Medicine received requests for a demo from many hospitals, including major hospitals, due to Anyfusion's competitiveness in the design and use of Anyfusion by many doctors who decided to apply it to patients based on improved clinical safety and evidence. S Hospital, the best national university that has already been decided, as well as S Hospital and K Hospital, the best private universities with over 100 years of history, A and C Hospitals, the largest hospitals, and many university hospitals. It served as an opportunity to promote Anyfusion widely and improve its reliability. It will be an opportunity to advance to the maturity stage.

In particular, professors at S and K universities were proposed to jointly develop the Smart Anyfusion Cylinder pump, which would be the most ideal and perfect pharmaceutical injection pump. Smart Anyfusion Cylinder pump will become a leader in the global market. In addition, the Smart Anyfusion Cylinder pump and Anyfusion Platform Project are expected to receive large contracts through joint development and investment as well as global business with large-scale partners in the United States.

We would like to thank all the medical staff who visited Booth. 

Thank you.